Prognosis of stage II and III colon carcinoma treated with adjuvant 5-FU or FOLFIRI in relation to microsatellite status, results of the PETACC-3 trial
Klingbiel, D × Saridaki, Z Roth, A D Bosman, F Delorenzi, M Tejpar, Sabine #
Kluwer Academic Publishers
Annals of Oncology vol:26 issue:1 pages:126-32
Although microsatellite instable (MSI) colon carcinoma (CC) has a more favorable prognosis than microsatellite stable (MSS) CC, the impact varies according to clinicopathological parameters. We studied how MSI status affects prognosis in a trial-based cohort of stage II and III CC patients, treated with 5-FU/LV or FOLFIRI.